SCHEMBL7122703

SCHEMBL7122703

CCCCCCCCN(C)c1ccc(-c2ccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
MCL1 Q07820 1/20 0.55
LMNA P02545 2/20 0.55
HTT P42858 1/20 0.55
PPARG P37231 9/20 0.54
RORC P51449 5/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
CYP3A4 P08684 2/20 0.54
MAPK1 P28482 2/20 0.54
TP53 P04637 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 1/20 0.54
NFKB1 P19838 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127053 1.00 MAPT (0.55) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7121757 0.99 MAPT (0.56) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7128387 0.96 MAPT (0.59) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7130309 0.92 PPARG (0.56) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7125943 0.92 PPARG (0.56) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7130566 0.92 MAPT (0.59) MAPTSMN1; SMN2NPC1RAB9AMCL1
Hydrochloric Acid SCHEMBL7121797 0.91 PPARG (0.55) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7132342 0.91 MAPT (0.58) MAPTSMN1; SMN2NPC1RAB9AMCL1
SCHEMBL7132440 0.91 MAPT (0.58) MAPTSMN1; SMN2NPC1RAB9AMCL1
Hydrochloric Acid SCHEMBL7124428 0.91 PPARG (0.55) MAPTSMN1; SMN2NPC1RAB9AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MAPT 4391/4885SMN1; SMN2 3743/4885NPC1 1152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.